Saturday 17 October 2026 Export SRPT’s income statement to Excel — free account

Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.2 billion, up 15.6% from fiscal 2024. In the quarter to June 2026, revenue fell 34.3%, EPS fell 102.5%, free cash flow fell 14.5% and total debt fell 25.6%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.

17.06 0.73 −4.10%

Follow SRPT

Alert me

Market cap: $1.9B
P/E: 0.0×
Fwd P/E: 4.4×
Dividend yield: —
F-score: 3/9
Altman Z: −0.97
Beneish M: −3.41
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	3	3	6	4
ROE Full definition →		(21.37%)	(53.47%)	4.91%	(9.48%)
ROA Full definition →		(7.66%)	(19.51%)	1.96%	(3.98%)
ROIC Full definition →		(5.26%)	(42.46%)	(1.51%)	(5.64%)
Return on Tangible Assets Full definition →		(12.57%)	(39.90%)	3.03%	(6.68%)
Average Days of Receivables Full definition →		59.84	66.12	65.98	69.66
Free Cash Flow per Share Full definition →		(3.88)	(3.15)	1.03	0.71
Free Cash Flow Full definition →		(388.84)	(315.33)	108.24	74.97
Capital Expenditures Full definition →		(144.20)	(109.85)	(67.04)	(36.04)
Other line items
Cash ROIC Full definition →		(12.13%)	(10.84%)	3.61%	2.37%
Accounts Receivable Turnover Full definition →		5.81	4.40	4.14	4.37
Accounts Payable Turnover Full definition →		5.39	3.39	7.16	8.61
Inventory Turnover Full definition →		0.70	1.01	0.83	0.85
Average Days of Payables Full definition →		59.87	122.09	31.68	23.04
Days of Inventory on Hand Full definition →		685.91	397.67	450.67	408.67
Tax Rate Full definition →		0.08	0.02	1.66	0.04
Research and Development Expense of Revenue Full definition →		57.86%	69.24%	41.32%	39.99%
Selling, General and Administrative Expense of Revenue Full definition →		21.85%	22.37%	21.38%	22.12%
Share Based Compensation of Revenue Full definition →		5.93%	5.61%	5.10%	5.00%
Operating CF/Net income Full definition →		0.90	0.29	2.69	(0.81)
Depreciation/Fixed assets Full definition →		0.11	0.11	0.12	0.13
Capex/Depreciation Full definition →		(3.79)	(2.80)	(1.63)	(0.86)
Revenue per Share Full definition →		24.08	21.96	20.80	18.73
Operating CF per Share Full definition →		(2.44)	(2.05)	1.67	1.05
Capex per Share Full definition →		(1.44)	(1.10)	(0.64)	(0.34)
Capex to Sales Full definition →		0.06	0.05	0.03	0.02

Show all line items

Columns are period end dates

Stockrow Weekly